PFE: Analysis & Opinions

  1. MWI Vet-IDEXX Bond 'Non-Exclusive' (revised) - Analyst Blog

    August 13, 2012
    MWI Veterinary Supply, Inc. (MWIV), a worldwide distributor of animal health products to veterinarians, has formed a ...
  2. The Week Ahead In Healthcare

    August 13, 2012
    The performance of healthcare stocks (as measured by ETFs) has begun to falter a bit, likely in part because Johnson ...
  3. Medivation Misses by a Wide Margin - Analyst Blog

    August 13, 2012
    Medivation Inc. (MDVN) reported second quarter loss of 15 cents per share, wider than the Zacks Consensus Estimate ...
  4. Pfizer Is Close to its 50 Day Moving Average

    August 13, 2012
    New York, August 10th (TradersHuddle.com) - Pfizer, Inc. (NYSE:PFE) closed the trading day at $23.87, near its 50 ...
  5. MWI Vet-IDEXX Bond 'Non-Exclusive' - Analyst Blog

    August 10, 2012
    MWI Veterinary Supply, Inc., (MWIV), a worldwide distributor of animal health products to veterinarians, has formed ...
  6. Loss at Vivus Wider-Than-Expected - Analyst Blog

    August 10, 2012
    Vivus Inc.'s (VVUS) second quarter 2012 loss of 24 cents per share was wider than the Zacks Consensus loss Estimate ...
  7. Dr. Reddy's Expands Portfolio - Analyst Blog

    August 09, 2012
    Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of Merck & Co's (MRK) ...
  8. Pfizer & JNJ End Bapineuzumab IV - Analyst Blog

    August 07, 2012
    Pfizer, Inc. (PFE) recently announced disappointing late-stage results on intravenous (IV) bapineuzumab. ...
  9. Pipeline Setback at Bristol-Myers - Analyst Blog

    August 03, 2012
    Bristol-Myers Squibb Company (BMY) recently suffered a pipeline setback when it voluntarily decided to halt a phase ...
  10. Company News for August 1, 2012 - Corporate Summary

    August 01, 2012
    "    BP plc (ADR) (NYSE:BP) posted second quarter earnings per share of $1.16, missing the Zacks Consensus Estimate ...
  11. Pfizer Beats on Lower Costs - Analyst Blog

    July 31, 2012
    Pfizer Inc. (PFE) posted second quarter earnings of 62 cents per share, well above the Zacks Consensus Estimate of ...
  12. How Bad Is Bad Enough? - Analyst Blog

    July 31, 2012
    All eyes are on the U.S. Federal Reserve and the European Central Bank, as the two critical central banks hold their ...
  13. Ahead of Wall Street - July 31, 2012 - Ahead of Wall Street

    July 31, 2012
    Tuesday, July 31, 2012 All eyes are on the U.S. Federal Reserve and the European Central Bank as the two critical ...
  14. Pfizer Second Quarter Earnings

    July 31, 2012
    Pfizer (NYSE:PFE) announced its results for the most recent quarter on July 31, 2012. Pfizer is a global ...
  15. Huntington Launches Sector Rotation ETF (HUSE)

    July 30, 2012
    Huntington, fresh off its initial foray into the ETF industry in June, has doubled the size of its lineup with the ...
  16. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take ...
  17. Amgen Beats, Raises Guidance - Analyst Blog

    July 27, 2012
    Amgen (AMGN) continued its strong performance in 2012 with second quarter earnings coming in at $1.82 per share, 31 ...
  18. Watson Beats; In-Line Guidance - Analyst Blog

    July 26, 2012
    Watson Pharmaceuticals Inc.'s (WPI) second quarter 2012 earnings (excluding special items) of $1.42 per share ...
  19. Pfizer Second Quarter Earnings Preview

    July 26, 2012
    Pfizer (NYSE:PFE) will release its second quarter results on Tuesday, July 31, 2012. Analysts are expecting earnings ...
  20. Lilly Beats & Lifts View Again - Analyst Blog

    July 25, 2012
    Eli Lilly & Company (LLY) reported second quarter 2012 adjusted earnings per share of 83 cents, 6 cents above the ...
Marketplace
Trading Center